TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Life Science Byrån LSB AB
Closing information (x1000 EUR)
| Closing information | 2025/12 | 2024/12 | 2023/12 |
| Turnover |
137
|
131 | |
| Financial expenses |
0
|
0 | |
| Earnings before taxes |
50
|
39 | |
| EBITDA |
49
|
38 | |
| Total assets |
140
|
130 | |
| Current assets |
95
|
103 | |
| Current liabilities |
16
|
18 | |
| Equity capital |
117
|
106 | |
| - share capital |
4
|
5 | |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2025/12 | 2024/12 | 2023/12 |
| Solvency |
83.6%
|
81.5% | |
| Turnover per employee |
137
|
131 | |
| Profit as a percentage of turnover |
36.5%
|
29.8% | |
| Return on assets (ROA) |
35.7%
|
30.0% | |
| Current ratio |
593.8%
|
572.2% | |
| Return on equity (ROE) |
42.7%
|
36.8% | |
| Change turnover |
11
|
-5 | |
| Change turnover % |
10%
|
9%
|
-4% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/12 | 2024/12 | 2023/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.